
Singulans Pharmaceuticals Private Limited
About Singulans Pharmaceuticals Private Limited
Data last updated:
Singulans Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the jewellery and fashion accessories sector. It was incorporated on 28 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U33309UP2017PTC089525.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Maneesh Kumar Singh and Ranjeet Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 77 L.D.A Colony Kanpur Road, Lucknow, Uttar Pradesh, India – 226005.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.97 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2,179 (net margin -0.2%) and EBITDA of -₹2,179 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 440% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Singulans Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 77 L.D.A Colony Kanpur Road, Lucknow, Uttar Pradesh, India – 226005
- IndustryJewelry & Fashion Accessories, Manufacturing, Watches And Clocks
To see the full contact details of Singulans Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Singulans Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Singulans Pharmaceuticals Private Limited, buy the company report.
Financials of Singulans Pharmaceuticals Private Limited
FY 2024 filings availableSingulans Pharmaceuticals Private Limited reported revenue of ₹11.97 Lakh (up 4428% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 440% over three years. EBITDA fell 140% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2,179 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,179 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Singulans Pharmaceuticals Private Limited, buy the company report.
Board of directors of Singulans Pharmaceuticals Private Limited
Singulans Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maneesh Kumar Singh | Director | 28 Jan 2017 | 9 Years 9 Months | Current |
| Ranjeet Singh | Director | 28 Jan 2017 | 9 Years 9 Months | Current |
| Vivek Vikram Verma | Director | 28 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Singulans Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Souris Pharmaceuticals Private Limited | ₹12.06 Lakh (FY 2025) | -7.0% | Bangalore, Karnataka, India | |||
| Zeinac Pharmaceuticals Private Limited | ₹12.05 Lakh (FY 2024) | 47.0% | Bareilly, Uttar Pradesh, India | |||
| Klyrich Pharmaceuticals Private Limited | ₹11.99 Lakh (FY 2025) | -18.0% | Lucknow, Uttar Pradesh, India | |||
| Sternum Pharmaceuticals Private Limited | ₹11.99 Lakh (FY 2023) | Ayodhya, Uttar Pradesh, India | ||||
| Singulans Pharmaceuticals Private Limitedthis company | ₹11.97 Lakh (FY 2024) | -₹2,179 | -0.2% | 4428.0% | Lucknow, Uttar Pradesh, India | |
| Primax Pharmaceuticals Private Limited | ₹11.89 Lakh (FY 2018) | 302.0% | Dhanbad, Jharkhand, India | |||
| Neowick Pharmaceuticals Private Limited | ₹11.87 Lakh (FY 2024) | 177.0% | Gorakhpur, Uttar Pradesh, India | |||
| Pansofy Pharmaceuticals Private Limited | ₹11.86 Lakh (FY 2024) | -8.0% | Mahoba, Uttar Pradesh, India |
To see the full peer comparison of Singulans Pharmaceuticals Private Limited, buy the company report.
Auditor
Singulans Pharmaceuticals Private Limited is audited by MITTAL AGRAWAL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MITTAL AGRAWAL & ASSOCIATES | FY 2017 | 423747 |
Shareholding
The shareholding of Singulans Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Singulans Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Singulans Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Singulans Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Singulans Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Singulans Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Maneesh Kumar Singh was appointed as Director on 28 Jan 2017.
Frequently asked questions
Singulans Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the jewelry and fashion accessories industry. It was incorporated on 28 January 2017 (9+ years old) and is registered under CIN U33309UP2017PTC089525.
Singulans Pharmaceuticals has 3 current directors:
- Maneesh Kumar Singh - Director
- Ranjeet Singh - Director
- Vivek Vikram Verma - Director
The latest financial statements of Singulans Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Singulans Pharmaceuticals is U33309UP2017PTC089525. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Singulans Pharmaceuticals was incorporated on 28 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Singulans Pharmaceuticals by revenue are Souris Pharmaceuticals Private Limited, Zeinac Pharmaceuticals Private Limited, Klyrich Pharmaceuticals Private Limited, Sternum Pharmaceuticals Private Limited, Primax Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Maneesh Kumar Singh was appointed as Director on 28 Jan 2017. Ranjeet Singh was appointed as Director on 28 Jan 2017. Vivek Vikram Verma was appointed as Director on 28 Jan 2017.
The registered office of Singulans Pharmaceuticals is at B – 77 L.D.A Colony Kanpur Road, Lucknow, Uttar Pradesh, India – 226005.
Singulans Pharmaceuticals operates in the jewelry and fashion accessories industry, in the manufacturing segment.
The compliance status of Singulans Pharmaceuticals is compliant as of 16 August 2026. The company is actively filing with the Registrar of Companies.
Singulans Pharmaceuticals can be reached at its registered office: B – 77 L.D.A Colony Kanpur Road, Lucknow, Uttar Pradesh, India – 226005.

